Expressions of Interest to participate in a market engagement process to support the future design of COVID-19 vaccination and other immunisation / vaccination deployment models

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-034f58-2022-09-22T08:53:21+01:00",
    "date": "2022-09-22T08:53:21+01:00",
    "ocid": "ocds-h6vhtk-034f58",
    "initiationType": "tender",
    "tender": {
        "id": "56363",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "Expressions of Interest to participate in a market engagement process to support the future design of COVID-19 vaccination and other immunisation / vaccination deployment models",
        "status": "planned",
        "classification": {
            "scheme": "CPV",
            "id": "85000000",
            "description": "Health and social work services"
        },
        "mainProcurementCategory": "services",
        "description": "The NHS response to the COVID-19 pandemic has required urgent action and commitment from providers and suppliers including primary care, secondary care, community health services and other groups, to run vaccine deployment sites and administer COVID-19 vaccines in a safe and effective way. With the changing nature of the clinical and policy response required by new strains emerging, surges of activity and new vaccines becoming available, the vaccine deployment strategy has been developmental and has required the Authority to react to circumstance to ensure vaccines could be administered as effectively as possible. As more is now known about COVID-19 the Authority is now able to look towards the future and the development of a stable and effective strategy for COVID-19 vaccine deployment and wider immunisation programmes. One of the requirements of the Authority is to ensure stability and continuity in the deployment of the COVID-19 vaccine and respond to any requirements, including new JCVI recommendations. In designing the future strategy the Authority recognises the need to hear from a wide range of stakeholders, which will help in determining the right provider mix and / or deployment model for the future of the COVID-19 vaccination programme and support the development of an integrated strategy for all NHS immunisation programmes. To this end the Authority is taking a staged approach: 1. July 2022 to Summer 2023 - Stabilise the current delivery model to minimise any impact on the current COVID-19 deployment up to the summer of 2023. 2. Summer 2022 - Seek to engage with the market to gain further information and insight to assist the Authority in developing a strategy for the future management and deployment of vaccinations. 3. Autumn to Spring 2022/23 - Develop a procurement strategy that enables the delivery of an integrated approach to vaccinations in 2023/24. The Authority expects to combine information provided as part of this market engagement process with insight derived from local systems' existing experience, plus evaluation of some innovative potential models of delivery, to develop a commissioning framework that enables an integrated approach to vaccinations in 2023/24. The Authority may seek support from the supply market to deliver these models. However, the Authority is now asking suitable, qualified and competent suppliers, able to manage and deploy vaccines, to indicate willingness to participate in a market engagement process and support the Authority in the design of its future strategy. Please provide contact details at following the link https://uk.eu-supply.com/login.asp?B=UK .The project reference is 56363.",
        "lots": [
            {
                "id": "1",
                "description": "The NHS response to the COVID-19 pandemic has required urgent action and commitment from providers and suppliers including primary care, secondary care, community health services and other groups, to run vaccine deployment sites and administer COVID-19 vaccines in a safe and effective way. With the changing nature of the clinical and policy response required by new strains emerging, surges of activity and new vaccines becoming available, the vaccine deployment strategy has been developmental and has required the Authority to react to circumstance to ensure vaccines could be administered as effectively as possible. As more is now known about COVID-19 the Authority is now able to look towards the future and the development of a stable and effective strategy for COVID-19 vaccine deployment and wider immunisation programmes. One of the requirements of the Authority is to ensure stability and continuity in the deployment of the COVID-19 vaccine and respond to any requirements, including new JCVI recommendations. In designing the future strategy the Authority recognises the need to hear from a wide range of stakeholders, which will help in determining the right provider mix and / or deployment model for the future of the COVID-19 vaccination programme and support the development of an integrated strategy for all NHS immunisation programmes. To this end the Authority is taking a staged approach: 1. July 2022 to Summer 2023 - Stabilise the current delivery model to minimise any impact on the current COVID-19 deployment up to the summer of 2023. 2. Summer 2022 - Seek to engage with the market to gain further information and insight to assist the Authority in developing a strategy for the future management and deployment of vaccinations. 3. Autumn to Spring 2022/23 - Develop a procurement strategy that enables the delivery of an integrated approach to vaccinations in 2023/24. The Authority expects to combine information provided as part of this market engagement process with insight derived from local systems' existing experience, plus evaluation of some innovative potential models of delivery, to develop a commissioning framework that enables an integrated approach to vaccinations in 2023/24. The Authority may seek support from the supply market to deliver these models. However, the Authority is now asking suitable, qualified and competent suppliers, able to manage and deploy vaccines, to indicate willingness to participate in a market engagement process and support the Authority in the design of its future strategy. Please provide contact details at following the link: https://uk.eu-supply.com/login.asp?B=UK . The project reference is 56363.",
                "status": "planned"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UKC"
                    },
                    {
                        "region": "UKD"
                    },
                    {
                        "region": "UKE"
                    },
                    {
                        "region": "UKF"
                    },
                    {
                        "region": "UKG"
                    },
                    {
                        "region": "UKH"
                    },
                    {
                        "region": "UKI"
                    },
                    {
                        "region": "UKJ"
                    },
                    {
                        "region": "UKK"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "communication": {
            "futureNoticeDate": "2022-07-08T00:00:00+01:00"
        },
        "coveredBy": [
            "GPA"
        ],
        "amendments": [
            {
                "id": "1",
                "unstructuredChanges": [
                    {
                        "oldValue": {
                            "text": "The NHS response to the COVID-19 pandemic has required urgent action and commitment from providers and suppliers including primary care, secondary care, community health services and other groups, to run vaccine deployment sites and administer COVID-19 vaccines in a safe and effective way. With the changing nature of the clinical and policy response required by new strains emerging, surges of activity and new vaccines becoming available, the vaccine deployment strategy has been developmental and has required the Authority to react to circumstance to ensure vaccines could be administered as effectively as possible. As more is now known about COVID-19 the Authority is now able to look towards the future and the development of a stable and effective strategy for COVID-19 vaccine deployment and wider immunisation programmes. One of the requirements of the Authority is to ensure stability and continuity in the deployment of the COVID-19 vaccine and respond to any requirements, including new JCVI recommendations. In designing the future strategy the Authority recognises the need to hear from a wide range of stakeholders, which will help in determining the right provider mix and / or deployment model for the future of the COVID-19 vaccination programme and support the development of an integrated strategy for all NHS immunisation programmes. To this end the Authority is taking a staged approach: 1. July 2022 to Summer 2023 - Stabilise the current delivery model to minimise any impact on the current COVID-19 deployment up to the summer of 2023. 2. Summer 2022 - Seek to engage with the market to gain further information and insight to assist the Authority in developing a strategy for the future management and deployment of vaccinations. 3. Autumn to Spring 2022/23 - Develop a procurement strategy that enables the delivery of an integrated approach to vaccinations in 2023/24. The Authority expects to combine information provided as part of this market engagement process with insight derived from local systems' existing experience, plus evaluation of some innovative potential models of delivery, to develop a commissioning framework that enables an integrated approach to vaccinations in 2023/24. The Authority may seek support from the supply market to deliver these models. However, the Authority is now asking suitable, qualified and competent suppliers, able to manage and deploy vaccines, to indicate willingness to participate in a market engagement process and support the Authority in the design of its future strategy. Please provide contact details at following the link https://uk.eu-supply.com/login.asp?B=UK .The project reference is 56363."
                        },
                        "newValue": {
                            "text": "The NHS response to the COVID-19 pandemic has required urgent action and commitment from providers and suppliers including primary care, secondary care, community health services and other groups, to run vaccine deployment sites and administer COVID-19 vaccines in a safe and effective way. With the changing nature of the clinical and policy response required by new strains emerging, surges of activity and new vaccines becoming available, the vaccine deployment strategy has been developmental and has required the Authority to react to circumstance to ensure vaccines could be administered as effectively as possible. As more is now known about COVID-19 the Authority is now able to look towards the future and the development of a stable and effective strategy for COVID-19 vaccine deployment and wider immunisation programmes. One of the requirements of the Authority is to ensure stability and continuity in the deployment of the COVID-19 vaccine and respond to any requirements, including new JCVI recommendations. In designing the future strategy the Authority recognises the need to hear from a wide range of stakeholders, which will help in determining the right provider mix and / or deployment model for the future of the COVID-19 vaccination programme and support the development of an integrated strategy for all NHS immunisation programmes. To this end the Authority is taking a staged approach: 1. July 2022 to Summer 2023 - Stabilise the current delivery model to minimise any impact on the current COVID-19 deployment up to the summer of 2023. 2. Summer 2022 - Seek to engage with the market to gain further information and insight to assist the Authority in developing a strategy for the future management and deployment of vaccinations. 3. Autumn to Spring 2022/23 - Develop a procurement strategy that enables the delivery of an integrated approach to vaccinations in 2023/24. The Authority expects to combine information provided as part of this market engagement process with insight derived from local systems' existing experience, plus evaluation of some innovative potential models of delivery, to develop a commissioning framework that enables an integrated approach to vaccinations in 2023/24. The Authority may seek support from the supply market to deliver these models. However, the Authority is now asking suitable, qualified and competent suppliers, able to manage and deploy vaccines, to indicate willingness to participate in a market engagement process and support the Authority in the design of its future strategy. Please provide contact details at following the link https://uk.eu-supply.com/login.asp?B=UK .The project reference is 56405"
                        },
                        "where": {
                            "section": "II.1.4"
                        }
                    },
                    {
                        "oldValue": {
                            "text": "The NHS response to the COVID-19 pandemic has required urgent action and commitment from providers and suppliers including primary care, secondary care, community health services and other groups, to run vaccine deployment sites and administer COVID-19 vaccines in a safe and effective way. With the changing nature of the clinical and policy response required by new strains emerging, surges of activity and new vaccines becoming available, the vaccine deployment strategy has been developmental and has required the Authority to react to circumstance to ensure vaccines could be administered as effectively as possible. As more is now known about COVID-19 the Authority is now able to look towards the future and the development of a stable and effective strategy for COVID-19 vaccine deployment and wider immunisation programmes. One of the requirements of the Authority is to ensure stability and continuity in the deployment of the COVID-19 vaccine and respond to any requirements, including new JCVI recommendations. In designing the future strategy the Authority recognises the need to hear from a wide range of stakeholders, which will help in determining the right provider mix and / or deployment model for the future of the COVID-19 vaccination programme and support the development of an integrated strategy for all NHS immunisation programmes. To this end the Authority is taking a staged approach: 1. July 2022 to Summer 2023 - Stabilise the current delivery model to minimise any impact on the current COVID-19 deployment up to the summer of 2023. 2. Summer 2022 - Seek to engage with the market to gain further information and insight to assist the Authority in developing a strategy for the future management and deployment of vaccinations. 3. Autumn to Spring 2022/23 - Develop a procurement strategy that enables the delivery of an integrated approach to vaccinations in 2023/24. The Authority expects to combine information provided as part of this market engagement process with insight derived from local systems' existing experience, plus evaluation of some innovative potential models of delivery, to develop a commissioning framework that enables an integrated approach to vaccinations in 2023/24. The Authority may seek support from the supply market to deliver these models. However, the Authority is now asking suitable, qualified and competent suppliers, able to manage and deploy vaccines, to indicate willingness to participate in a market engagement process and support the Authority in the design of its future strategy. Please provide contact details at following the link: https://uk.eu-supply.com/login.asp?B=UK . The project reference is 56363."
                        },
                        "newValue": {
                            "text": "The NHS response to the COVID-19 pandemic has required urgent action and commitment from providers and suppliers including primary care, secondary care, community health services and other groups, to run vaccine deployment sites and administer COVID-19 vaccines in a safe and effective way. With the changing nature of the clinical and policy response required by new strains emerging, surges of activity and new vaccines becoming available, the vaccine deployment strategy has been developmental and has required the Authority to react to circumstance to ensure vaccines could be administered as effectively as possible. As more is now known about COVID-19 the Authority is now able to look towards the future and the development of a stable and effective strategy for COVID-19 vaccine deployment and wider immunisation programmes. One of the requirements of the Authority is to ensure stability and continuity in the deployment of the COVID-19 vaccine and respond to any requirements, including new JCVI recommendations. In designing the future strategy the Authority recognises the need to hear from a wide range of stakeholders, which will help in determining the right provider mix and / or deployment model for the future of the COVID-19 vaccination programme and support the development of an integrated strategy for all NHS immunisation programmes. To this end the Authority is taking a staged approach: 1. July 2022 to Summer 2023 - Stabilise the current delivery model to minimise any impact on the current COVID-19 deployment up to the summer of 2023. 2. Summer 2022 - Seek to engage with the market to gain further information and insight to assist the Authority in developing a strategy for the future management and deployment of vaccinations. 3. Autumn to Spring 2022/23 - Develop a procurement strategy that enables the delivery of an integrated approach to vaccinations in 2023/24. The Authority expects to combine information provided as part of this market engagement process with insight derived from local systems' existing experience, plus evaluation of some innovative potential models of delivery, to develop a commissioning framework that enables an integrated approach to vaccinations in 2023/24. The Authority may seek support from the supply market to deliver these models. However, the Authority is now asking suitable, qualified and competent suppliers, able to manage and deploy vaccines, to indicate willingness to participate in a market engagement process and support the Authority in the design of its future strategy. Please provide contact details at following the link: https://uk.eu-supply.com/login.asp?B=UK . The project reference is 56405."
                        },
                        "where": {
                            "section": "II.2.4"
                        }
                    }
                ]
            },
            {
                "id": "2",
                "unstructuredChanges": [
                    {
                        "newValue": {
                            "classifications": [
                                {
                                    "scheme": "CPV",
                                    "id": "85100000",
                                    "description": "Health services"
                                }
                            ]
                        },
                        "where": {
                            "section": "II.2.2"
                        }
                    }
                ]
            },
            {
                "id": "3",
                "unstructuredChanges": [
                    {
                        "oldValue": {
                            "text": "However, the Authority is now asking suitable, qualified and competent suppliers, able to manage and deploy vaccines, to indicate willingness to participate in a market engagement process and support the Authority in the design of its future strategy. Please provide contact details at following the link https://uk.eu-supply.com/login.asp?B=UK .The project reference is 56363."
                        },
                        "newValue": {
                            "text": "However, the Authority is now asking suitable, qualified and competent suppliers, able to manage and deploy vaccines, to indicate willingness to participate in a market engagement process and support the Authority in the design of its future strategy. Please provide contact details at following the link https://uk.eu-supply.com/login.asp?B=UK .The project reference is 56363. The closing date for submitting this information is midnight on 7th October 2022."
                        },
                        "where": {
                            "section": "II.1.4"
                        }
                    }
                ]
            },
            {
                "id": "4",
                "unstructuredChanges": [
                    {
                        "oldValue": {
                            "classifications": [
                                {
                                    "scheme": "CPV",
                                    "id": "85000000",
                                    "description": "Health and social work services"
                                }
                            ]
                        },
                        "newValue": {
                            "classifications": [
                                {
                                    "scheme": "CPV",
                                    "id": "85100000",
                                    "description": "Health services"
                                }
                            ]
                        },
                        "where": {
                            "section": "II.1.2"
                        }
                    },
                    {
                        "oldValue": {
                            "text": "However, the Authority is now asking suitable, qualified and competent suppliers, able to manage and deploy vaccines, to indicate willingness to participate in a market engagement process and support the Authority in the design of its future strategy. Please provide contact details at following the link https://uk.eu-supply.com/login.asp?B=UK .The project reference is 56363."
                        },
                        "newValue": {
                            "text": "However, the Authority is now asking suitable, qualified and competent suppliers, able to manage and deploy vaccines, to indicate willingness to participate in a market engagement process and support the Authority in the design of its future strategy. Please provide contact details at following the link https://uk.eu-supply.com/login.asp?B=UK .The project reference is 56405. The closing date for submitting this information is midnight on Friday 7th October 2022"
                        },
                        "where": {
                            "section": "II.1.4"
                        }
                    }
                ]
            }
        ]
    },
    "parties": [
        {
            "id": "GB-FTS-3717",
            "name": "NHS England",
            "identifier": {
                "legalName": "NHS England",
                "noIdentifierRationale": "notOnAnyRegister"
            },
            "address": {
                "streetAddress": "Quarry House",
                "locality": "Leeds",
                "region": "UK",
                "postalCode": "LS2 7UE",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Warren Simms",
                "email": "agem.procurementeastmids@nhs.net",
                "url": "https://uk.eu-supply.com/login.asp?B=UK"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.england.nhs.uk/",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-3717",
        "name": "NHS England"
    },
    "language": "en"
}